P02829 (HSP82_YEAST) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
ATP-dependent molecular chaperone HSP82 UniProtKBInterProSTRINGInteractive Modelling
709 aa; Sequence (Fasta) ;
4 identical sequences: Saccharomyces cerevisiae: N1NXP6, A0A6A5Q4M3, A6ZW16, B3LKJ2
It is possible new templates exist for this target since these models were created.
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of an Hsp90-Sba1 closed chaperone complex |
Heteromer P28707; | 2×ATP; | ||||
| Assess | ||||||
| The Structure of the complex between Aha1 and HSP90 |
Heteromer Q12449; | 1×GOL; | ||||
| Assess | ||||||
| The Structure of the complex between Aha1 and HSP90 |
Heteromer Q12449; | |||||
| Assess | ||||||
| Complex of Hsp90 and P50 |
Heteromer Q16543; | |||||
| Assess | ||||||
| The NMR high resolution structure of yeast Tah1 in complex with the Hsp90 C-terminal tail |
Heteromer P25638; | |||||
| Assess | ||||||
| The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90 |
Heteromer Q14318; | |||||
| Assess | ||||||
| Crystal structure of Tom71 complexed with Hsp82 C-terminal fragment |
Heteromer P38825; | 1×CL; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of an Hsp90-Sba1 closed chaperone complex | homo-6-mer | |||||
| Assess | ||||||
| Crystal Structure of the Hsp90-LA1011 Complex | homo-2-mer | |||||
| Assess | ||||||
| STRUCTURE OF THE ORTHORHOMBIC FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE | homo-2-mer | 4×GOL; | ||||
| Assess | ||||||
| Yeast Hsp90 N-terminal domain LI-IV mutant with Radicicol | homo-2-mer | 2×RDC; | ||||
| Assess | ||||||
| Macrolactone Inhibitor bound to HSP90 N-term | homo-2-mer | 2×13C; 3×GOL; | ||||
| Assess | ||||||
| Yeast Hsp90 N-terminal domain LI-IV mutant with ADP | homo-2-mer | 2×ADP; | ||||
| Assess | ||||||
| Macrolactone Inhibitor bound to HSP90 N-term | homo-2-mer | 2×13N; 2×GOL; | ||||
| Assess | ||||||
| Hsp90 N-terminal domain bound to macrolactam analogues of radicicol. | homo-2-mer | 2×7FK; | ||||
| Assess | ||||||
| Macrolactone Inhibitor bound to HSP90 N-term | homo-2-mer | 2×13I; | ||||
| Assess | ||||||
| Hsp90 complexed with a resorcylic acid macrolactone. | homo-2-mer | 2×XD6; 8×GOL; | ||||
| Assess | ||||||
| Hsp90 N-terminal domain bound to macrolactam analogues of radicicol. | homo-2-mer | 2×L4V; | ||||
| Assess | ||||||
| E88G-N92L Mutant of N-Term HSP90 complexed with Geldanamycin | homo-2-mer | 2×GDM; | ||||
| Assess | ||||||
| Hsp90 N-terminal domain bound to macrolactam analogues of radicicol. | homo-2-mer | 2×BO5; | ||||
| Assess | ||||||
| STRUCTURE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE IN COMPLEX WITH GELDANAMYCIN | homo-2-mer | 2×GDM; | ||||
| Assess | ||||||
| RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE | homo-2-mer | 2×RDC; | ||||
| Assess | ||||||
| The structure of modified benzoquinone ansamycins bound to yeast N- terminal Hsp90 | homo-2-mer | 2×62U; 6×NI; | ||||
| Assess | ||||||
| The structure of modified benzoquinone ansamycins bound to yeast N- terminal Hsp90 | homo-2-mer | 2×4QS; | ||||
| Assess | ||||||
| STRUCTURE OF THE TETRAGONAL FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE | homo-2-mer | |||||
| Assess | ||||||
| ADP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE | homo-2-mer | 2×ADP; | ||||
| Assess | ||||||
| ATP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE | homo-2-mer | 2×ADP; | ||||
| Assess | ||||||
| Yeast Hsp90 N-terminal domain LI-IV mutant with Geldanamycin | homo-2-mer | 2×GDM; 4×GOL; | ||||
| Assess | ||||||
| The structure of modified benzoquinone ansamycins bound to yeast N- terminal Hsp90 | homo-2-mer | 2×814; 6×NI; | ||||
| Assess | ||||||
| The structure of modified benzoquinone ansamycins bound to yeast N- terminal Hsp90 | homo-2-mer | 2×59C; 2×CL; | ||||
| Assess | ||||||
| A RADICICOL ANALOGUE BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAP… | homo-2-mer | 2×P2N; | ||||
| Assess | ||||||
| Middle Domain of HSP90 | monomer | 5×CD; 1×MG; | ||||
| Assess | ||||||
| Analogues of radicicol bound to the ATP-binding site of Hsp90. | monomer | 1×M1S; | ||||
| Assess | ||||||
| Structure of a Hsp90 Inhibitor bound to the N-terminus of Yeast Hsp90. | monomer | 1×CT5; | ||||
| Assess | ||||||
| Yeast Hsp82 N-terminal domain-Geldanamycin complex: effects of mutants 98-99 KS-AA | monomer | 1×GDM; 2×GOL; | ||||
| Assess | ||||||
| Yeast Hsp82 N-terminal domain: effects of mutants 98-99 KS-AA | monomer | |||||
| Assess | ||||||
| Structure Of The Hsp90 Inhibitor 7-O-carbamoylpremacbecin Bound To The N- Terminus Of Yeast Hsp90 | monomer | 1×BC6; 3×SO4; | ||||
| Assess | ||||||
| E88G-N92L Mutant of N-Term HSP90 complexed with Geldanamycin | monomer | 1×GDM; 1×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF THE HSP90 INHIBITOR MACBECIN BOUND TO THE N-TERMINUS OF YEAST HSP90. | monomer | 1×BC2; 1×GOL; | ||||
| Assess | ||||||
| Radicicol analogues bound to the ATP site of HSP90 | monomer | 1×NP4; | ||||
| Assess | ||||||
| Analogues of radicicol bound to the ATP-binding site of Hsp90 | monomer | 1×NP5; | ||||
| Assess | ||||||
| Yeast Hsp82 in complex with the novel Hsp90 inhibitor Radester amine | monomer | 1×RDE; | ||||
| Assess | ||||||
| Yeast HSP82 in complex with the Novel HSP90 Inhibitor 8-(6-Bromo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(… | monomer | 1×H64; | ||||
| Assess | ||||||
| STRUCTURE OF A HSP90 INHIBITOR BOUND TO THE N-TERMINUS OF YEAST HSP90. | monomer | 1×KJ2; | ||||
| Assess | ||||||
| Yeast HSP82 in complex with the novel HSP90 Inhibitor Radamide | monomer | 1×RDA; 5×GOL; | ||||
| Assess | ||||||
| L89V, L93I and V136M Mutant of N-Term HSP90 complexed with Geldanamycin | monomer | 1×GDM; 1×GOL; | ||||
| Assess | ||||||
| The structure of modified benzoquinone ansamycins bound to yeast N- terminal Hsp90 | monomer | 1×8TO; | ||||
| Assess | ||||||
| Hsp90 Delta24-N210 mutant | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6xlf.1.A | monomer | 0.79 | 1×ANP; 1×MG; 1×K; | 97.73 | ||
| Assess | ||||||
| 8ffv.1.B | monomer | 0.73 | 61.76 | |||
| Assess | ||||||
| 8u1n.1.A | homo-2-mer | 0.67 | 1×ATP; | 62.32 | ||
| Assess | ||||||